Publication Name	World Journal of Gastroenterology
Manuscript ID	17661
Country	Japan

Received	2015-03-17 18:44
Peer-Review Started	2015-03-18 09:07
To Make the First Decision	2015-04-23 14:44
Return for Revision	2015-04-28 19:53
Revised	2015-05-21 12:49
Second Decision	2015-08-03 10:12
Accepted by Journal Editor-in-Chief	2015-08-06 08:59
Accepted by Company Editor-in-Chief	2015-08-31 15:59
Articles in Press	2015-08-31 15:59
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-09-09 17:31
Publish the Manuscript Online	2015-09-28 11:42

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Potentiality of immunotherapy against hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Nobuhiro Tsuchiya, Yu Sawada, Itaru Endo, Yasushi Uemura and Tetsuya Nakatsura
Funding Agency and Grant Number	Funding Agency Grant Number Ono Pharmaceutical Co., Ltd. to Nakatsura T Ono Pharmaceutical Co., Ltd. Nakatsura T
Corresponding Author	Tetsuya Nakatsura, MD, PhD, Chief, Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan. tnakatsu@east.ncc.go.jp
Key Words	Cell transfer immunotherapy; Cytokine therapy; Hepatocellular carcinoma; Immune checkpoint inhibitors; Immunotherapy; Tumor-associated antigens therapy
Core Tip	Hepatocellular carcinoma (HCC) has a high incidence and poor prognosis worldwide. Tumor immunotherapy is a promising novel therapy that will lead to improvements in both treatment-associated toxicity and outcome. This review summarizes current knowledge concerning the progress of immunotherapy for HCC.
Publish Date	2015-09-28 11:42
Citation	Tsuchiya N, Sawada Y, Endo I, Uemura Y, Nakatsura T. Potentiality of immunotherapy against hepatocellular carcinoma. World J Gastroenterol 2015; 21(36): 10314-10326
URL	http://www.wjgnet.com/1007-9327/full/v21/i36/10314.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i36.10314

Full Article (PDF)	WJG-21-10314.pdf
Full Article (Word)	WJG-21-10314.doc
Manuscript File	17661-Review.doc
Answering Reviewers	17661-Answering reviewers.pdf
Audio Core Tip	17661-Audio core tip.wma
Conflict-of-Interest Disclosure Form	17661-Conflict-of-interest statement.pdf
Copyright License Agreement	17661-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	17661-Language certificate.pdf
Peer-review Report	17661-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	17661-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	17661-Scientific misconduct check.pdf
Scientific Editor Work List	17661-Scientific editor work list.pdf